Posted by europerep on May 17, 2015, at 13:15:35
In reply to Re: Viibryd in Europe, posted by jkl77 on May 17, 2015, at 13:03:10
Well, that ranking is based on the number of prescriptions per year. That number alone really says more about marketing than about the efficacy of the drug. Many people would consider MAOIs the gold standard for depression treatment, yet they rank very low in prescriptions per year.
Anyway, I wasn't trying to bash vilazodone, I certainly don't know enough about it to make a qualified evaluation.
poster:europerep
thread:1078997
URL: http://www.dr-bob.org/babble/20150407/msgs/1079026.html